Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Drugs in Clinical Development for Chronic Obstructive Pulmonary Disease

Respiration (2005) 72 (1): 105–112.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
A novel triazine-aryl-bis-indole derivative inhibits both phosphodiesterase IV and expression of cell adhesion molecules
  • Tanima Banerjee
  • Dipak Kar
  • Palakodety Radha Krishna
  • Sunchu Prabhakar
  • Rajesh Nomula
  • Venkata Satyanarayana Mallula
  • Hajari Ravindranath
  • Gattu Sridhar
  • Ramesh Adepu
  • Gourishetty Srikanth
  • Ulaganathan Mabalirajan
  • Balaram Ghosh
  • Parasuraman Jaisankar
  • Rakesh Johri
  • Dolonchapa Chakraborty
  • Vani Mishra
  • Jasmeet Kaur Chhabra
  • Mamta Shukla
  • Bhola Nath Paul
  • Santu Bandyopadhyay
  • Siddhartha Roy
  • Gangavaram V. M. Sharma
  • Arun Bandyopadhyay
RSC Advances (2015) 5 (86): 70271.
Bacterial vaccines in chronic obstructive pulmonary disease: effects on clinical outcomes and cytokine levels
  • Salvador Ruso
  • Francisco M. Marco
  • Juan A. Martínez‐Carbonell
  • José A. Carratalá
APMIS (2015) 123 (7): 556.
Arformoterol tartrate in the treatment of COPD
  • Mario Cazzola
  • Nicola A Hanania
  • Maria G Matera
Expert Review of Respiratory Medicine (2010) 4 (2): 155.
Formation of an unusual product in the reaction of a 1,2,5‐thiadiazolidine 1,1‐dioxide‐derived thioether with sulfuryl chloride
  • Dengfeng Dou
  • Erach R. Talaty
  • Curtis E. Moore
  • John C. Bullinger
  • David M. Eichhorn
  • William C. Groutas
Journal of Heterocyclic Chemistry (2009) 46 (4): 669.
Discovery of Novel Quaternary Ammonium Derivatives of (3R)-Quinuclidinol Esters as Potent and Long-Acting Muscarinic Antagonists with Potential for Minimal Systemic Exposure after Inhaled Administration: Identification of (3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane Bromide (Aclidinium Bromide)
  • María Prat
  • Dolors Fernández
  • M. Antonia Buil
  • María I. Crespo
  • Gaspar Casals
  • Manuel Ferrer
  • Laia Tort
  • Jordi Castro
  • Juan M. Monleón
  • Amadeu Gavaldà
  • Montserrat Miralpeix
  • Israel Ramos
  • Teresa Doménech
  • Dolors Vilella
  • Francisca Antón
  • Josep M. Huerta
  • Sonia Espinosa
  • Manuel López
  • Sonia Sentellas
  • Marisa González
  • Joan Albertí
  • Victor Segarra
  • Alvaro Cárdenas
  • Jorge Beleta
  • Hamish Ryder
Journal of Medicinal Chemistry (2009) 52 (16): 5076.
A Comparative Study on Chronic Obstructive Pulmonary and Pneumonia Diseases Diagnosis using Neural Networks and Artificial Immune System
  • Orhan Er
  • Cengiz Sertkaya
  • Feyzullah Temurtas
  • A. Cetin Tanrikulu
Journal of Medical Systems (2009) 33 (6): 485.
Mechanism-based inhibitors of serine proteases with high selectivity through optimization of S′ subsite binding
  • Yi Li
  • Dengfeng Dou
  • Guijia He
  • Gerald H. Lushington
  • William C. Groutas
Bioorganic & Medicinal Chemistry (2009) 17 (10): 3536.
A Study on Chronic Obstructive Pulmonary Disease Diagnosis Using Multilayer Neural Networks
  • Orhan Er
  • Feyzullah Temurtas
Journal of Medical Systems (2008) 32 (5): 429.
Developments in drugs for the treatment of chronic obstructive pulmonary disease
  • Tammy SY Mui
  • SF Paul Man
  • Don D Sin
Expert Review of Clinical Immunology (2008) 4 (3): 365.
Advances in the management of chronic obstructive pulmonary disease
  • Laura Meinke
  • Rajinder Chitkara
  • Ganesh Krishna
Expert Opinion on Pharmacotherapy (2007) 8 (1): 23.
Chronic obstructive pulmonary disease: Histopathology, inflammation and potential therapies
  • Néstor A. Molfino
  • Peter K. Jeffery
Pulmonary Pharmacology & Therapeutics (2007) 20 (5): 462.
Emerging drugs for the treatment of chronic obstructive pulmonary disease
  • Samir Malhotra
  • S F Paul Man
  • Don D Sin
Expert Opinion on Emerging Drugs (2006) 11 (2): 275.
COPD — zukünftige Therapieoptionen
  • J. C. Virchow
Der Pneumologe (2006) 3 (2): 129.
Biological targets for therapeutic interventions in COPD: clinical potential
  • Girolamo Pelaia
  • Alessandro Vatrella
  • Luca Gallelli
  • Teresa Renda
  • Mario Caputi
  • Rosario Maselli
  • Serafino A Marsico
International Journal of COPD (2006) 1 (3): 321.
Current World Literature
Current Opinion in Allergy & Clinical Immunology (2006) 6 (1): 67.
Ultra long-acting β2-agonists in development for asthma and chronic obstructive pulmonary disease
  • Mario Cazzola
  • Maria Gabriella Matera
  • Jan Lötvall
Expert Opinion on Investigational Drugs (2005) 14 (7): 775.
  • Online ISSN 1423-0356
  • Print ISSN 0025-7931
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal